RE - ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES

被引：2

作者：

KUROKAWA, M ^{[1
]}

FUTAMURA, Y ^{[1
]}

OBATA, M ^{[1
]}

SHIBUTANI, Y ^{[1
]}

机构：

[1] MOCHIDA PHARMACEUT CO LTD,TOXICOL LAB,SHIZUOKA 426,JAPAN

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1995年 / 87卷 / 21期

关键词：

D O I：

10.1093/jnci/87.21.1638

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1638 / 1639

页数：2

共 14 条

[1]

BERTOFT E, 1984, FEBS LETT, V173, P213, DOI 10.1016/0014-5793(84)81049-2

[2] THE SCID MOUSE MUTANT - DEFINITION, CHARACTERIZATION, AND POTENTIAL USES [J].

BOSMA, MJ ;

CARROLL, AM .

ANNUAL REVIEW OF IMMUNOLOGY, 1991, 9 :323-350

[3] ENHANCED CANCER GROWTH IN MICE ADMINISTERED DAILY HUMAN-EQUIVALENT DOSES OF SOME H-1-ANTIHISTAMINES - PREDICTIVE IN-VITRO CORRELATES [J].

BRANDES, LJ ;

WARRINGTON, RC ;

ARRON, RJ ;

BOGDANOVIC, RP ;

FANG, W ;

QUEEN, GM ;

STEIN, DA ;

TONG, JG ;

ZABORNIAK, CLF ;

LABELLA, FS .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (10) :770-775

[4] DOUBLE AND TRIPLE STAINING METHODS FOR STUDYING THE PROLIFERATIVE ACTIVITY OF HUMAN B-LYMPHOID AND T-LYMPHOID CELLS [J].

CAMPANA, D ;

COUSTANSMITH, E ;

JANOSSY, G .

JOURNAL OF IMMUNOLOGICAL METHODS, 1988, 107 (01) :79-88

[5]

HASUMI K, 1978, CANCER-AM CANCER SOC, V42, P2675, DOI 10.1002/1097-0142(197812)42:6<2675::AID-CNCR2820420624>3.0.CO

[6]

2-G

[7]

KUROKAWA M, 1995, JPN PHARM THER, V23, P311

[8]

PLA M, 1991, NOUV REV FR HEMATOL, V33, P489

[9]

RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO

[10]

2-Z

← 1 2 →